Here are four key statistics:
1. Through 2020, orphan drugs’ annual sales are likely to increase 12 percent each year.
2. The average annual price tag for orphan drugs totaled $111,820 in 2014. Comparatively, mainstream drugs cost $23,331, on average, that year.
3. Excluding genetics, estimates expect global orphan drug sales to comprise slightly more than 20 percent of all drug sales.
4. The Department of Health sent a report to Congress in December 2016 which found orphan drugs cost $1 billion to develop, compared to $2.6 billion for mass market drugs.
More articles on quality & infection control:
North America leads global infection control market with 39.5% market share: 5 takeaways
ASC Quality Collaboration report: 9 key benchmarks from Q3 2016
Trump’s take on pharmaceutical companies: ‘Getting away with murder’
